The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
1983 • 7,404 citations
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
1996 • 2,410 citations
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 • 2,049 citations
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
1993 • 2,032 citations
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
1993 • 1,908 citations
Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
1998 • 931 citations
Interferon beta‐lb in the treatment of multiple sclerosis
1995 • 899 citations
The Danish Multiple Sclerosis Registry: a 50-year follow-up
1999 • 132 citations
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administration
1998 • 92 citations